Pharmaceuticals News
Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.
Therapeutic Assessment Market Review and Pipeline Landscape for Lung Transplant Rejection H2 2016
This research study provides comprehensive data on the therapeutic evelopment for lung transplant rejection along with the analysis based on various stages of development, drug profiles, route of administration (RoA), mechanism of action (MoA) and molecule type. - November 25, 2016 - Market Research Hub
Platelet Rich Plasma (PRP) Market Size, Share, Growth, Trends and Forecast Report to 2023: Credence Research
CredenceResearch.com has announced the addition of "Platelet Rich Plasma (PRP) Market Size, Share, Growth, Trends and Forecast Report To 2023: Credence Research" Market Research Report to their Database. - November 24, 2016 - Credence Research
Mayne Pharma Launches Temozolomide Capsules in U.S. – Generic Alternative to Temodar®
Mayne Pharma Inc. (Mayne Pharma) is pleased to announce the U.S. launch of temozolomide capsules, 5mg, 20mg, 100mg, 140mg, 180mg and 250mg, which is a generic version of branded Temodar®. Temozolomide capsules are indicated for the treatment of adult patients with newly diagnosed cancerous... - November 23, 2016 - Mayne Pharma USA
Gensco Pharma Announces ColciGel®, a New Transdermal Medication Indicated for the Treatment of Acute Gout Flares in Adults
A new transdermal gel has been developed and is now available by prescription only to treat the symptoms of gout attacks. ColciGel® is a transdermal medication that provides rapid relief of pain at the first sign of acute gout flares without gastrointestinal problems. - November 22, 2016 - Gensco Pharma
Astero®, Manufactured by Gensco Laboratories, is the Only FDA Approved Prescription Hydrogel with Topical Anesthetic, Indicated for Painful Wounds
Astero® is indicated for painful wounds such as stage I-IV pressure ulcers, Venous stasis ulcers, ulcerations caused by mixed vascular etiologies, Diabetic skin ulcers, first and second degree burns, post-surgical incisions, cuts and abrasions. Astero® is specifically formulated to create a moist healing environment, which promotes granulation, epithelialization, and autolytic debridement, while providing prolonged anesthesia of the wound, lessening the need for systemic pain medications. - November 19, 2016 - Gensco Pharma
Pharma Cold Chain Distribution Updates from MHRA, IATA, GSK, Teva, J&J, World Courier, Finnair
SMi Group reports: World Courier, Finnair, MHRA, IATA, Teva, GSK, J&J, Sanofi will meet in London this December at Cold Chain Distribution 2016 - November 17, 2016 - SAE Media Group
Novartis Explore Novel Approaches to Disease Modelling and Organoid Technology
Novartis to present case studies at 3D Cell Culture in London in February. - November 12, 2016 - SAE Media Group
Erythropoietin Drugs Market is Expected to Reach $11.9 Billion, Globally, by 2020
A new report by Allied Market Research titled, "Erythropoietin Drugs Market - Global Opportunity Analysis and Industry Forecast, 2013- 2020" forecasts the Global EPO market to reach $11.9 billion by 2020, with promising CAGR of 9.7% from 2014 to 2020. Darbepoetin alfa is a fastest growing... - November 10, 2016 - Allied Market Research
Global Drug Delivery Devices Market New Report by Data Bridge Market Research
Global Drug Delivery Devices Market, By Product Type (Oral Solid, Liquid, Semi-Solid), Injectable, Topical, Pulmonary (MDI, DPI, Nebulizers), Nasal, Ocular, Implantable, Transmucosal), By End-User (Hospitals, Clinics, Home Healthcare, Community Healthcare, Others), By Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Direct Tenders, Online Pharmacy), By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa, Rest of the World) – Trends and Forecast to 2022 - November 10, 2016 - Data Bridge Market Research
ALFA to Feature Breakthrough Technology for Rapid Diagnostic Tests at MEDICA 2016
ALFA Scientific Designs, Inc., a rapid immunoassay, point-of-care (POC) test development and manufacturing company based in San Diego, California, will exhibit at the MEDICA 2016 World Forum for Medicine in Düsseldorf Germany from November 14-17, 2016. ALFA will welcome visitors and customers... - November 08, 2016 - Alfa Scientific Designs
Marcus Evans: Industry Experts from Takeda, Sanofi, Amgen, Abbott and Menarini to Give In-Depth Insights
This forum highlights the way Pharma companies reengineer their business growth strategies to expand to broad markets; cultivate modern sales force with smarter marketing techniques and technology; and keeping mature brands alive in the every changing Pharma environment. - November 05, 2016 - Marcus Evans Group
NuvOx Pharma Awarded NIH Grant to Develop Technology to Increase Sensitivity and Specificity of Breast Cancer Diagnosis
NuvOx Pharma, a Tucson based biotechnology company, has been awarded a grant from the National Cancer Institute for $298,820.00 entitled, “B7-H3-Targeted Contrast Agent for Ultrasonic Imaging of Breast Cancer.” Evan Unger, MD, co-founder of NuvOx, a co-principal investigator of the... - November 03, 2016 - NuvOx Therapeutics
Global Albumin Market USD 300 Million by 2020, Research Study Published by iHealthcareAnalyst, Inc.
The global albumin market is estimated to reach USD 300 Million in 2020, expanding at a CAGR of 2.4% from 2016 to 2020. - November 01, 2016 - iHealthcareAnalyst, Inc.
Radiopharmaceuticals Market USD 350 Million by 2020 - iHealthcareAnalyst, Inc.
Radiopharmaceuticals Market 2013-2020 report estimates the global radiopharmaceuticals market to reach nearly USD 350 Million in 2020, at a CAGR of 4.9% from 2016 to 2020 - iHealthcareAnalyst, Inc. Visit the Radiopharmaceuticals Market 2013-2020 report... - November 01, 2016 - iHealthcareAnalyst, Inc.
Nanomedicine Market USD 170 Billion by 2020, Published by iHealthcareAnalyst, Inc.
The global nanomedicine market is estimated to reach USD 170 Billion in 2020, growing at a CAGR of 8.9% from 2016 to 2020, according to a market research report Nanomedicine Market 2013-2020, published by iHealthcareAnalyst, Inc. Visit the Nanomedicine Market 2013-2020 report at... - November 01, 2016 - iHealthcareAnalyst, Inc.
Opioid Induced Constipation Drugs Market USD 2.14 Billion by 2020, Published by iHealthcareAnalyst, Inc.
The global opioid induced constipation drugs market is estimated to reach USD 2.14 Billion in 2020, growing at a CAGR of 31.3% from 2016 to 2020, according to a market research report Opioid Induced Constipation Drugs Market 2013-2020, published by iHealthcareAnalyst, Inc. Visit the Opioid Induced... - October 29, 2016 - iHealthcareAnalyst, Inc.
Menopausal Hot Flashes Therapy Market USD 4.7 Billion by 2020 - iHealthcareAnalyst, Inc.
Menopausal Hot Flashes Therapy Market 2013-2020 report estimates the global menopausal hot flashes therapy market to reach nearly USD 4.7 Billion in 2020, at a CAGR of 3.8% from 2016 to 2020 - iHealthcareAnalyst, Inc. Visit the Menopausal Hot Flashes Therapy Market 2013-2020 report... - October 29, 2016 - iHealthcareAnalyst, Inc.
Mayne Pharma Launches Budesonide Capsules in the United States
Mayne Pharma announces the U.S. launch of budesonide capsules in a 3 mg dose. Budesonide is a generic alternative to Entocort EC®, which is used as a treatment for patients with mild to moderate Crohn’s disease. The capsules reflect the company's focus on developing and manufacturing controlled-release and potent pharmaceuticals. - October 29, 2016 - Mayne Pharma USA
Safer Lock Locking Prescription Bottles Now Sold Nationwide Thru Precision Disposables
Precision Disposables is helping prevent prescription drug abuse nationwide by carrying Safer Lock locking prescription bottles. "We believe Safer Lock is truly innovative and saves lives," says Bruce Capagli, COO for Precision Disposables. "Precision is always seeking... - October 28, 2016 - Gatekeeper Innovation
Janssen Explores How to Embed Social Media Into Multi-Channel Campaigns
Janssen Digital and Multi-channel Marketing Manager joins speaker lineup for Social Media in the Pharmaceutical Industry in London. - October 28, 2016 - SAE Media Group
Makers Nutrition Hires Pat Gillespie as New VP of Sales
Seasoned sales executive with high-level expertise helps expand Nutraceutical Company. - October 27, 2016 - Makers Nutrition, LLC
Hyaluronic Acid Injections Market USD 10.5 Billion by 2020, Research Study Published by iHealthcareAnalyst, Inc.
According to a market research report Hyaluronic Acid Injections Market 2013-2020 published by iHealthcareAnalyst, Inc., the global hyaluronic acid injections market is estimated to reach USD 10.5 Billion in 2020, expanding at a CAGR of 8.8% from 2016 to 2020. Visit the Hyaluronic Acid Injections... - October 27, 2016 - iHealthcareAnalyst, Inc.
Heparin Anticoagulant Market USD 10.8 Billion by 2020, Published by iHealthcareAnalyst, Inc.
The global heparin anticoagulant market is estimated to reach USD 10.8 Billion in 2020, growing at a CAGR of 4.4% from 2016 to 2020, according to a market research report Heparin Anticoagulant Market 2013-2020, published by iHealthcareAnalyst, Inc. Visit the Heparin Anticoagulant Market 2013-2020... - October 27, 2016 - iHealthcareAnalyst, Inc.
Fragment-Based Drug Discovery Market USD 650 Million by 2020, Published by iHealthcareAnalyst, Inc.
The global fragment-based drug discovery market is estimated to reach USD 650 Million in 2020, growing at a CAGR of 10.6% from 2016 to 2020, according to a market research report Fragment-based Drug Discovery Market 2013-2020, published by iHealthcareAnalyst, Inc. Visit the Fragment-based Drug... - October 26, 2016 - iHealthcareAnalyst, Inc.
Chemotherapy-Induced Nausea and Vomiting Drugs Market USD 1.8 Billion by 2020, Research Study by iHealthcareAnalyst, Inc.
According to a market research report, Chemotherapy-induced Nausea and Vomiting Drugs Market 2013-2020, published by iHealthcareAnalyst, Inc., the global chemotherapy-induced nausea and vomiting drugs market is estimated to reach USD 1.8 Billion in 2020, expanding at a CAGR of 8.4% from 2016 to... - October 26, 2016 - iHealthcareAnalyst, Inc.
Exocrine Pancreatic Insufficiency Diagnostics Market USD 2.3 Billion by 2020 - iHealthcareAnalyst, Inc.
Exocrine Pancreatic Insufficiency Diagnostics Market 2013-2020 report estimates the global exocrine pancreatic insufficiency diagnostics market to reach nearly USD 2.3 Billion in 2020, at a CAGR of 8.9% from 2016 to 2020 - iHealthcareAnalyst, Inc. Visit the Exocrine Pancreatic Insufficiency... - October 26, 2016 - iHealthcareAnalyst, Inc.
Anxiety Disorders and Depression Treatment Market USD 17.8 Billion by 2020, Published by iHealthcareAnalyst, Inc.
The global anxiety disorders and depression treatment market is estimated to reach USD 17.8 Billion in 2020, growing at a CAGR of 0.9% from 2016 to 2020, according to a market research report Anxiety Disorders and Depression Treatment Market 2013-2020, published by iHealthcareAnalyst, Inc. - October 25, 2016 - iHealthcareAnalyst, Inc.
Acute Ischemic Stroke Diagnosis and Treatment Market USD 1.7 Billion by 2020 - iHealthcareAnalyst, Inc.
Acute Ischemic Stroke Diagnosis and Treatment Market 2013-2020 report estimates the global acute ischemic stroke diagnosis and treatment market to reach nearly USD 1.7 Billion in 2020, at a CAGR of 5.5% from 2016 to 2020 - iHealthcareAnalyst, Inc. - October 25, 2016 - iHealthcareAnalyst, Inc.
New Research Benchmarks Clinical Investigator Satisfaction with Pharma Sponsors and Central Laboratories
5-year Study Tracks Central Lab Performance and Identifies Opportunities for Pharma Sponsors to Improve Clinical Investigator Satisfaction. - October 24, 2016 - Life Science Strategy Group, LLC
Non-Alcoholic Steatohepatitis (NASH) Market is Expected to Reach $1.6 Billion, Globally, by 2020
A new report by Allied Market Research entitled, "Non-Alcoholic Steatohepatitis (NASH) Market- Global Opportunity Analysis and Industry Forecast, 2013- 2020," indicates that the global nonalcoholic Steatohepatitis (NASH) market would reach $1.6 billion by 2020 registering CAGR of 25.6%... - October 23, 2016 - Allied Market Research
New Global Radiotherapy Market Report by Data Bridge Market Research
Global Radiotherapy Market, By Therapy (Beam Radiotherapy (IGRT, IMRT, VMAT, Tomotherapy, 3D CRT, Proton Beam, Stereotactic), Brachytherapy (LDR, HDR), Systemic Radiotherapy), By Product Type (Cyberknife, Gammaknife, Linac, Proton Beam, Systemic Radiotherapy, Seeds, Afterloaders), By Indication (Prostate & Breast Cancer)), By Geography – Trends and Forecast to 2022 - October 20, 2016 - Data Bridge Market Research
Regenerative Medicine Market to Reach $30,237 Million, Globally by 2022
The prominent potential of regenerative medicine to replace, repair, and regenerate damaged tissues and organs has boosted the market growth. - October 16, 2016 - Allied Market Research
Oncology Drugs Market is Expected to Reach $111.9 Billion, by 2020
The cancer drugs market is driven by the growing prevalence of various types of cancer, increasing demand of biological and targeted drug therapies, continuous patent expiry of key cancer drugs and the rising impact of biosimilars. - October 16, 2016 - Allied Market Research
Global Self-Injections Market New Report by Data Bridge Market Research
Global Self-Injections Market, By Product (Devices (Needle-Free Injectors, Auto Injectors, Pen Injectors, Wearable Injectors), Formulations), Dosage Form (Single Dose, Multi-Dose), Therapeutic Application (Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Others), By Route Of Administration, By End-User, By Distribution, By Geography - Trends and Forecast to 2022 - October 15, 2016 - Data Bridge Market Research
ORTHOReBIRTH USA Attending National Spine Meeting
ORTHOReBIRTH USA of Georgetown, Texas, is attending the North American Spine Society meeting for 2016. The meeting starts on October 26 and ends on October 29 in Boston, Massachusetts. The premier spine meeting in North America, NASS 2016, has hundreds of companies from around the globe coming... - October 14, 2016 - ORTHOReBIRTH USA
Japanese Biologics Company Expands to Texas
ORTHOReBIRTH Co Ltd., a leading manufacturer of novel biologic products, announced the formation of ORTHOReBIRTH USA, previously Siena Biologics (Austin). The U.S. introduction of ORTHOReBIRTH’s products signals a new high-quality resource for doctors and patients throughout the... - October 14, 2016 - ORTHOReBIRTH USA
Radiopharmaceuticals Market to Reach $8,207 Million, by 2022
According to a new report published by Allied Market Research, titled, "Global Radiopharmaceuticals Market," the radiopharmaceuticals market is expected to generate revenue of $8,207 million by 2022. The diagnostics segment held a dominant share in the world radiopharmaceuticals market in... - October 14, 2016 - Allied Market Research
Global Injectable Drug Delivery Market New Report by Data Bridge Market Research
Global Injectable Drug Delivery Market, By Type (Devices (Conventional Injection Devices, Self Injection Devices), Formulations, By Applications, By Usage Pattern, By Mode of Administration, By End User, By Geography - Trends and Forecast to 2022 - October 09, 2016 - Data Bridge Market Research
Leading Industry Innovators to Explore 3D Cell Culture Technology in February 2017
AstraZeneca, GSK, Lonza, MHRA, Novartis, and Sanofi join speaker lineup at SMi’s inaugural event on 3D Cell Culture in February. - October 09, 2016 - SAE Media Group
Serene K. Zeni, Of Counsel, Dickinson Wright PLLC to Speak at the Knowledge Group’s Understanding the Recent Changes to the Stark Law Regulations
The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Serene K. Zeni, Of Counsel, Dickinson Wright PLLC will speak at the Knowledge Group’s webcast entitled: “Understanding the Recent Changes to the Stark Law Regulations: What Lies Ahead in 2016 and Beyond Live Webcast.” This event is scheduled for Thursday, November 3, 2016 from 12:00 PM to 2:00 PM (ET). - October 06, 2016 - The Knowledge Group
Jack L. Caynon, III, with Sussman Shank LLP to Speak at the Knowledge Group’s Event Understanding the Recent Changes to the Stark Law Regulations
The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Jack L. Caynon, III, Special Counsel, Sussman Shank LLP will speak at the Knowledge Group’s webcast entitled: “Understanding the Recent Changes to the Stark Law Regulations: What Lies Ahead in 2016 and Beyond Live Webcast.” This event is scheduled for Thursday, November 3, 2016 from 12:00 PM to 2:00 PM (ET). - October 05, 2016 - The Knowledge Group
Global Intravenous Solutions Market 2022 – Industry Analysis, Market Size, Competitive Trends: Credence Research
New Market Research Reports Title "Global Intravenous Solutions Market 2022 – Industry Analysis, Market Size, Competitive Trends: Credence Research" Has Been Added to Credenceresearch.com Report Database. - October 02, 2016 - Credence Research
B2BGateway Provides Fully Integrated EDI Solution for Aptean Ross to Legacy Pharmaceutical Packaging
Rapid global growth in pharma packaging industry prompts leading supplier Legacy Pharmaceutical Packaging to further automate their supply chain processes thru cloud based EDI technology. - September 30, 2016 - B2BGateway.Net
Global Biopreservation Market 2022 – Industry Analysis, Market Size, Competitive Trends: Credence Research
CredenceResearch.com has announced the addition of "Global Biopreservation Market 2022 – Industry Analysis, Market Size, Competitive Trends: Credence Research" Market Research Report to their Database. - September 30, 2016 - Credence Research
Global Hot and Cold Therapy Packs Market 2022 – Industry Analysis, Market Size, Competitive Trends: Credence Research
Credenceresearch.com has announced the addition of "Global Hot and Cold Therapy Packs Market 2022 – Industry Analysis, Market Size, Competitive Trends: Credence Research" Market Research Report to their Database. - September 29, 2016 - Credence Research
Spherium Biomed Starts Efficacy Trial Cyclatop for the Treatment of Atopic Dermatitis in Adults and Infants
The clinical trial is a pilot study (the Cyclatop study) for the evaluation of SP14019-F-01 topical solution for the treatment of atopic dermatitis. It is designed to investigate the safety, tolerability, pharmacokinetics and efficacy of SP14019-F-01 across all group ages for the treatment of mild... - September 29, 2016 - Spherium Biomed
STATIC™ – New Video Broadcast Series Uncovering “The Good, The Bad and the Ugly” of Nutritional Products
Virun® Nutra-BioSciences® Creates New Series of Video Broadcasts Called STATIC, Focusing on Nutrition Found in Finished Products. - September 27, 2016 - VIRUN
EpiPen® Insurance Cover Launched Via EpiPenIns
Following the recent uproar about Mylan, licensed manufacturer of EpiPen® products, a consortium of Lloyd's names and reinsurance professionals have decided to offer a cost effective option to replace a used EpiPen®. Via the website EpiPenIns, a replacement service (or financial... - September 23, 2016 - EpiPenIns
IQ4I Research & Consultancy Published a New Report on "Pharmaceutical Excipients Global Market – Forecast to 2022"
Excipients are inactive substances helping modulate solubility, bioavailability and stability of active substances in a drug and form the major part of any medicinal product. There is demand for the development of novel and co-processed excipients for the various route of administration. - September 22, 2016 - IQ4I Research & Consultancy Pvt. Ltd.
Batavia Biosciences Receives Grant to Develop New Vaccine Against Rotavirus
Batavia Biosciences received an $8 million grant from the Bill & Melinda Gates Foundation to develop a low cost manufacturing process to bring an affordable rotavirus vaccine to the global health market. This vaccine aims to save many young children’s lives worldwide. - September 21, 2016 - Batavia Biosciences